Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For ARCC
Valuation Weak
28%
Profitability n.A.
Fin. Growth Weak
17%
Leverage & Liquidity Balanced
50%
Per Share Metrics Positive
67%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q4 Q1 Δ in %
Current Ratio -14.72 1.82 2.13
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 1088.26 -321.00 27.01
Naive Interpretation member
2 Per Share
Metric Q4 Q1 Δ in %
Book Value 2.58 20.09 19.58
Cash -7.74 0.86 0.94
Capex 0.00 0.00 0.00
Free Cash Flow 94.34 -0.04 -0.63
Revenue 7.90 0.84 0.78
Naive Interpretation member
3 Profitability
Metric Q4 Q1 Δ in %
Gross Margin 147.55 1.42 0.57
Operating Margin 4.36 0.99 0.95
ROA 6.67 0.02 0.02
ROE 2.57 0.04 0.04
ROIC 14.64 0.02 0.02
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of ARCC is permitted for members.
5 Growth
The "Growth Entry" for the Focus of ARCC is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of ARCC is permitted for members.